Venture Life has reported a sharp uplift in revenue for 2025, as the AIM-listed consumer healthcare group continued to focus on scaling its core portfolio of branded products. 

The Berkshire-based company delivered revenues of £35.1 million, up 32% year-on-year, with proforma growth of 11.1% driven mainly by higher volumes sold. 

Growth was led by its “power brands” range, including Balance Activ, Lift/Glucogel, Earol and Health & Her/Him, with the business performing strongly after increased investment in advertising and promotion.